View Filing Data

Restructuring and Impairment Charges [Abstract]

Acquisitions

4. Acquisitions

RPC Group Plc

On March 8, 2019, the Company issued an announcement pursuant to Rule 2.7 of the UK City Code on Takeovers and Mergers disclosing the terms of an all-cash firm offer for the entire issued and to be issued share capital of RPC Group Plc (“RPC”). Pursuant to the offer, RPC shareholders will be entitled to receive 793 pence in cash for each RPC share (implying a value of approximately £3.3 billion, or $4.3 billion using the exchange rate at the time of the offer). Aggregate consideration will be approximately £5.0 billion, or $6.5 billion, including refinancing of RPC’s net debt, using the exchange rate at the time of the offer. The Company has entered into certain foreign exchange forward contracts to partially mitigate its currency exchange rate risk associated with the GBP denominated purchase price. Refer to Note 9. Financial Instruments and Fair Value Measurements for further information.

On April 18, 2019, the requisite majority of RPC shareholders voted to approve the RPC transaction. The transaction remains subject to, among other things, receipt of antitrust clearances and satisfaction of other customary closing conditions. Antitrust approvals have been obtained in the United States, Turkey, South Africa and the European Union. Filings for the other antitrust clearances required to be obtained to satisfy the other applicable conditions (in Mexico, Russia and China) have been made.

The Company expects to complete the RPC acquisition early in the third quarter of calendar year 2019. To finance the all-cash purchase, the Company intends to obtain permanent financing prior to the completion of the acquisition.

RPC is a leading plastic product design and engineering company that works responsibly across a broad range of industries from food to technical components, healthcare to industrial with total revenue of £3.7 billion for the twelve-month period ended March 31, 2018. It is a global business with 189 operating sites in 34 countries that are strategically placed to support customers on a local, national and international basis, as well as providing multi-site security of supply. RPC manufactures in five of the major polymer conversion processes (consisting of injection molding, blow molding, thermoforming, rotational molding and blown film extrusion) allowing RPC to produce innovative and sustainable value added products.

Laddawn, Inc.

In August 2018, the Company acquired Laddawn, Inc. ("Laddawn") for a purchase price of $242 million, which is preliminary and subject to adjustment. Laddawn is a custom bag and film manufacturer with a unique-to-industry e-commerce sales platform. The acquired business is operated in our Engineered Materials segment. To finance the purchase, the Company used existing liquidity.

The acquisition has been accounted for under the purchase method of accounting and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary estimates of fair value at the acquisition date. The results of Laddawn have been included in the consolidated results of the Company since the date of the acquisition. The Company has not finalized the allocation of the purchase price to the fair value of the assets acquired and liabilities assumed. The assets acquired and liabilities assumed consisted of working capital of $26 million, property and equipment of $39 million, intangible assets of $98 million, and goodwill of $79 million. The working capital includes a $2 million step up of inventory to fair value. The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes.

Clopay Plastic Products Company, Inc.

In February 2018, the Company acquired Clopay Plastic Products Company, Inc. ("Clopay") for a purchase price of $475 million. Clopay is an innovator in the development of printed breathable films, elastic films, and laminates with product offerings uniquely designed for applications used in a number of markets including: hygiene, healthcare, construction and industrial protective apparel. The acquired business is operated within our Health, Hygiene & Specialties segment. To finance the purchase, the Company issued $500 million aggregate principal amount of 4.5% second priority notes through a private placement offering.

The acquisition has been accounted for under the purchase method of accounting, and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on fair values at the acquisition date. The results of Clopay have been included in the consolidated results of the Company since the date of the acquisition. The Company has recognized goodwill on this transaction primarily as a result of expected cost synergies, and expects goodwill to be deductible for tax purposes. The following table summarizes the purchase price allocation and estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital (a)	$	70
Property and equipment		164
Intangible assets		125
Goodwill		111
Other assets and long-term liabilities		5

(a) Includes a $3 million step up of inventory to fair value

Accounts Receivable Factoring Agreements	6 Months Ended
Accounts Receivable Factoring Agreements	Mar. 30, 2019
Accounts Receivable Factoring Agreements [Abstract]
Accounts Receivable Factoring Agreements	5. Accounts Receivable Factoring Agreements The Company has entered into various factoring agreements, both in the U.S. and at a number of foreign subsidiaries, to sell certain receivables to unrelated third-party financial institutions. The Company accounts for these transactions in accordance with ASC 860, "Transfers and Servicing" ("ASC 860"). ASC 860 allows for the ownership transfer of accounts receivable to qualify for sale treatment when the appropriate criteria is met, which permits the Company to present the balances sold under the program to be excluded from Accounts receivable, net on the Consolidated Balance Sheets. Receivables are considered sold when (i) they are transferred beyond the reach of the Company and its creditors, (ii) the purchaser has the right to pledge or exchange the receivables, and (iii) the Company has surrendered control over the transferred receivables. In addition, the Company provides no other forms of continued financial support to the purchaser of the receivables once the receivables are sold. There were no amounts outstanding from financial institutions related to U.S. based programs at March 30, 2019 or September 29, 2018. Gross amounts factored under these U.S. based programs at March 30, 2019 and September 29, 2018 were $203 million and $162 million, respectively. The fees associated with transfer of receivables for all programs were not material for any of the periods presented.

Restructuring and Impairment Charges

6 Months Ended

Mar. 30, 2019

Restructuring and Impairment Charges

6. Restructuring and Impairment Charges

The Company incurred restructuring costs related to severance charges associated with acquisition integrations and facility exit costs. The tables below set forth the significant components of the restructuring charges recognized, by segment:

	Quarterly Period Ended				Two Quarterly Periods Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
Engineered Materials	$	1	$	2	$	1	$	2
Health, Hygiene & Specialties		2		12		12		22
Consumer Packaging		2		1		3		2
Consolidated	$	5	$	15	$	16	$	26

The table below sets forth the activity with respect to the restructuring accrual at March 30, 2019:

	Employee Severance and Benefits			Facility Exit Costs			Non-cash Impairment Charges			Total
Balance at September 29, 2018	$	9		$	4		$	—		$	13
Charges		6			3			7			16
Non-cash asset impairment		—			—			(7	)		(7	)
Cash payments		(11	)		(2	)		—			(13	)
Balance at March 30, 2019	$	4		$	5		$	—		$	9

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

6 Months Ended

Mar. 30, 2019

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

7. Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets:

	March 30, 2019		September 29, 2018
Employee compensation	$	107	$	113
Accrued taxes		73		72
Rebates		56		58
Interest		46		49
Derivative instruments		18		—
Tax receivable agreement obligation		12		16
Restructuring		9		13
Accrued operating expenses		112		95
	$	433	$	416

The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets:

	March 30, 2019		September 29, 2018
Uncertain tax positions	$	70	$	67
Deferred purchase price		44		40
Pension liability		42		45
Lease retirement obligation		40		39
Derivative instruments		21		12
Sale-lease back deferred gain		20		21
Transition tax		17		18
Tax receivable agreement obligation		12		23
Other		24		24
	$	290	$	289

Long-Term Debt

6 Months Ended

Mar. 30, 2019

Long-Term Debt [Abstract]

Long-Term Debt

8. Long-Term Debt

Long-term debt consists of the following:

	Maturity Date	March 30, 2019			September 29, 2018
Term loan	February 2020^(a)	$	700		$	800
Term loan	January 2021		814			814
Term loan	October 2022		1,545			1,545
Term loan	January 2024		490			493
Revolving line of credit	May 2020		—			—
5 ¹/₂% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
5 ¹/₈% Second Priority Senior Secured Notes	July 2023		700			700
4 ¹/₂% Second Priority Senior Secured Notes	February 2026		500			500
Debt discounts and deferred fees			(38	)		(43	)
Capital leases and other	Various		116			135
Total long-term debt			5,727			5,844
Current portion of long-term debt			(37	)		(38	)
Long-term debt, less current portion		$	5,690		$	5,806

(a)	The Company classifies the term loan as long-term based on our intent and ability (through the use of alternative financing including our revolving line of credit, if necessary) to refinance prior to its maturity date.

The Company was in compliance with all debt covenants for all periods presented.

Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense, net through maturity.

During fiscal 2019, the Company has made $122 million of repayments on long-term borrowings using existing liquidity.

Financial Instruments and Fair Value Measurements

6 Months Ended

Mar. 30, 2019

Financial Instruments and Fair Value Measurements [Abstract]

Financial Instruments and Fair Value Measurements

9. Financial Instruments and Fair Value Measurements

In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies. These financial instruments are not used for trading or other speculative purposes. For those derivative instruments that are designated and qualify as hedging instruments, the Company must designate the hedging instrument, based upon the exposure being hedged, as a fair value hedge, cash flow hedge, or a hedge of a net investment in a foreign operation.

To the extent hedging relationships are found to be effective, as determined by FASB guidance, changes in the fair value of the derivatives are offset by changes in the fair value of the related hedged item and recorded to Accumulated other comprehensive loss. Any identified ineffectiveness, or changes in the fair value of a derivative not designated as a hedge, is recorded to the Consolidated Statements of Income.

Cross-Currency Swaps

The Company is party to certain cross-currency swap agreements with a notional amount of 250 million euro to effectively convert a portion of our fixed-rate U.S. dollar denominated term loans, including the monthly interest payments, to fixed-rate euro-denominated debt. The swap agreements mature in May 2022. The risk management objective is to manage foreign currency risk relating to net investments in certain European subsidiaries denominated in foreign currencies and reduce the variability in the functional currency cash flows of a portion of the Company’s term loans. Changes in fair value of the derivative instruments are recognized in a component of Accumulated other comprehensive loss, to offset the changes in the values of the net investments being hedged.

Foreign Exchange Forward Contracts — RPC Acquisition

In connection with the announced, proposed acquisition of RPC, the Company entered into certain foreign exchange forward contracts to partially mitigate the currency exchange rate risk associated with the GBP denominated purchase price. At March 30, 2019, the Company had outstanding forward contracts totaling £2.7 billion and are expected to settle upon the closing of the transaction. For the quarter ended March 30, 2019, the Company recognized an unrealized loss of $18 million in Other expense, net in the Consolidated Statement of Income associated with the forward contracts.

Interest Rate Swaps

The primary purpose of the Company’s interest rate swap activities is to manage cash flow variability associated with our outstanding variable rate term loan debt.

During fiscal 2017 the Company modified various term loan rates and maturities. In conjunction with these modifications the Company realigned existing swap agreements which resulted in the de-designation of the original hedge and re-designation of the modified swaps as effective cash flow hedges. The amounts included in Accumulated other comprehensive loss at the date of de-designation are being amortized to Interest expense through the terms of the original swaps.

As of March 30, 2019, the Company effectively had (i) a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.000%, with an effective date in May 2017 and expiration in May 2022, (ii) a $1 billion interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.808% with an effective date in June 2018 and expiration in September 2021, and (iii) a $400 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 2.533% with an effective date in February 2019 and expiration in July 2023.

The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. The categorization of the framework used to value the instruments is considered Level 2, due to the analysis that incorporates observable market inputs including foreign currency spot and forward rates, various interest rate curves, and obtained from pricing data quoted by various banks, third party sources and foreign currency dealers. Balances on a gross basis are as follows:

Derivatives Instruments	Hedge Designation	Balance Sheet Location	March 30, 2019		September 29, 2018
Cross-currency swaps	Designated	Other assets	$	6	$	—
Cross-currency swaps	Designated	Other long-term liabilities		—		11
Interest rate swaps	Designated	Other assets		2		16
Interest rate swaps	Not designated	Other assets		—		—
Interest rate swaps	Designated	Other long-term liabilities		21		—
Interest rate swaps	Not designated	Other long-term liabilities		—		1
Foreign exchange forward contracts	Not designated	Other current liabilities		18		—

The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows:

		Quarterly Period Ended						Two Quarterly Periods Ended
Derivative Instruments	Statements of Income Location	March 30, 2019			March 31, 2018			March 30, 2019			March 31, 2018
Cross-currency swaps	Interest expense, net	$	(1	)	$	(1	)	$	(3	)	$	(2	)
Foreign exchange forward contracts	Other expense, net		18			—			18			—
Interest rate swaps	Interest expense, net		(5	)		1			(9	)		3

The amortization related to unrealized losses in Accumulated other comprehensive loss is expected to be $7 million in the next 12 months.

Non-recurring Fair Value Measurements

The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition. The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values. The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value. These assets that are subject to our annual impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant and equipment. The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist. The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2018 assessment. No impairment indicators were identified in the current quarter.

Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of March 30, 2019 and September 29, 2018, along with the impairment loss recognized on the fair value measurement during the period:

	As of March 30, 2019
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,938		2,938		—
Definite lived intangible assets		—		—		1,015		1,015		—
Property, plant, and equipment		—		—		2,449		2,449		7
Total	$	—	$	—	$	6,650	$	6,650	$	7

	As of September 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,944		2,944		—
Definite lived intangible assets		—		—		1,092		1,092		—
Property, plant, and equipment		—		—		2,488		2,488		—
Total	$	—	$	—	$	6,772	$	6,772	$	-

The Company's financial instruments consist primarily of cash and cash equivalents, long-term debt, interest rate and cross-currency swap agreements, foreign exchange forward contracts, and capital lease obligations. The book value of our marketable long-term indebtedness exceeded fair value by $10 million as of March 30, 2019. The Company's long-term debt fair values were determined using Level 2 inputs as other significant observable inputs were not available.

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Income Taxes	6 Months Ended
Income Taxes	Mar. 30, 2019
Income Taxes [Abstract]
Income Taxes	10. Income Taxes In December 2017, the U.S. government enacted comprehensive tax legislation commonly referred to as the Tax Cuts and Jobs Act (the “Tax Act”). The transitional impacts of the Tax Act resulted in a transition benefit of $95 million in the six month period ended March 31, 2018. The effective tax rate was 23% for the quarterly period ended March 30, 2019 and was positively impacted by 4% from the share-based compensation excess tax benefit deduction, 1% from research and development credits, and other discrete items. These favorable items were offset by increases of 4% from U.S. state income taxes, 2% from foreign valuation allowance, and other discrete items. The effective tax rate was 22% for the two quarterly periods ended March 30, 2019 and was positively impacted by 3% from the share-based compensation excess tax benefit, 1% from research and development credits, and other discrete items. These favorable items were partially offset by increases of 4% from U.S. state taxes, 2% from foreign valuation allowance, and other discrete items.

Operating Segments

6 Months Ended

Mar. 30, 2019

Operating Segments [Abstract]

Operating Segments

11. Operating Segments

The Company's operations are organized into three operating segments: Engineered Materials, Health, Hygiene & Specialties, and Consumer Packaging. The structure is designed to align us with our customers, provide optimal service, and drive future growth in a cost efficient manner. Selected information by reportable segment is presented in the following tables:

	Quarterly Period Ended				Two Quarterly Periods Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
Net sales:
Engineered Materials	$	628	$	655	$	1,297	$	1,303
Health, Hygiene & Specialties		683		706		1,385		1,283
Consumer Packaging		639		606		1,240		1,157
Total net sales	$	1,950	$	1,967	$	3,922	$	3,743
Operating income:
Engineered Materials	$	74	$	94	$	168	$	182
Health, Hygiene & Specialties		57		41		106		78
Consumer Packaging		54		53		87		91
Total operating income	$	185	$	188	$	361	$	351
Depreciation and amortization:
Engineered Materials	$	29	$	27	$	60	$	56
Health, Hygiene & Specialties		50		49		104		95
Consumer Packaging		53		56		106		110
Total depreciation and amortization	$	132	$	132	$	270	$	261

	March 30, 2019		September 29, 2018
Total assets:
Engineered Materials	$	1,997	$	1,998
Health, Hygiene & Specialties		3,772		3,913
Consumer Packaging		3,215		3,220
Total assets	$	8,984	$	9,131

Total goodwill:
Engineered Materials	$	630	$	632
Health, Hygiene & Specialties		899		902
Consumer Packaging		1,409		1,410
Total goodwill	$	2,938	$	2,944

Selected information by geography is presented in the following tables:

	Quarterly Period Ended				Two Quarterly Periods Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
Net sales:
North America	$	1,595	$	1,601	$	3,200	$	3,067
South America		88		80		184		154
Europe		210		226		414		396
Asia		57		60		124		126
Total net sales	$	1,950	$	1,967	$	3,922	$	3,743

	March 30, 2019		September 29, 2018
Long-lived assets:
North America	$	5,653	$	5,764
South America		327		320
Europe		437		463
Asia		300		299
Total Long-lived assets	$	6,717	$	6,846

Selected information by product line is presented in the following tables:

	Quarterly Period Ended						Two Quarterly Periods Ended
	March 30, 2019			March 31, 2018			March 30, 2019			March 31, 2018
Net sales:
Performance Materials		40			45			39			46
Engineered Products		60			55			61			54
Engineered Materials		100	%		100	%		100	%		100	%

Health		17			18			17			19
Hygiene		51			43			52			43
Specialties		32			39			31			38
Health, Hygiene & Specialties		100	%		100	%		100	%		100	%

Rigid Open Top		43			41			44			42
Rigid Closed Top		57			59			56			58
Consumer Packaging		100	%		100	%		100	%		100	%

Contingencies and Commitments	6 Months Ended
Contingencies and Commitments	Mar. 30, 2019
Contingencies and Commitments [Abstract]
Contingencies and Commitments	12. Contingencies and Commitments The Company is party to various legal proceedings involving routine claims which are incidental to its business. Although the Company's legal and financial liability with respect to such proceedings cannot be estimated with certainty, management believes that any ultimate liability would not be material to its financial statements. The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.

Share Repurchase Program	6 Months Ended
Share Repurchase Program	Mar. 30, 2019
Share Repurchase Program [Abstract]
Share Repurchase Program	13. Share Repurchase Program In fiscal 2018, the Company announced a $500 million share repurchase program. Berry may repurchase shares through the open market, privately negotiated transactions, or other programs, subject to market conditions. This authorization has no expiration date and may be suspended at any time. During the quarterly period ended March 30, 2019, the Company repurchased approximately 380 thousand shares for $18 million. For the two quarterly periods ended March 30, 2019, the Company repurchased approximately 1,512 thousand shares for $72 million. As of March 30, 2019, $393 million of authorized share repurchases remain available to the Company.

Basic and Diluted Net Income Per Share

6 Months Ended

Mar. 30, 2019

Basic and Diluted Net Income Per Share [Abstract]

Basic and Diluted Net Income Per Share

14. Basic and Diluted Net Income Per Share

Basic net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents. Diluted net income per share is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common share equivalents outstanding for the period determined using the treasury-stock method and the if-converted method. For purposes of this calculation, stock options are considered to be common stock equivalents and are only included in the calculation of diluted net income per share when their effect is dilutive. For the three and six months ended March 30, 2019, 2 million and 5 million shares, respectively, were excluded from the diluted net income per share calculation as their effect would be anti-dilutive.

The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations.

	Quarterly Period Ended				Two Quarterly Periods Ended
(in millions, except per share amounts)	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
Numerator
Net income	$	74	$	90	$	162	$	253
Denominator
Weighted average common shares outstanding - basic		130.5		131.3		130.8		131.0
Dilutive shares		3.3		4.5		3.1		4.9
Weighted average common and common equivalent shares outstanding - diluted		133.8		135.8		133.9		135.9

Per common share income
Basic	$	0.57	$	0.69	$	1.24	$	1.93
Diluted	$	0.55	$	0.66	$	1.21	$	1.86

Accumulated Other Comprehensive Loss

6 Months Ended

Mar. 30, 2019

Accumulated Other Comprehensive Loss [Abstract]

Accumulated Other Comprehensive Loss

15. Accumulated Other Comprehensive Loss

The components and activity of Accumulated other comprehensive loss are as follows:

Quarterly Period Ended	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at December 29, 2018	$	(179	)	$	(13	)	$	15		$	(177	)
Other comprehensive income (loss) before reclassifications		6			—			(16	)		(10	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(4	)		(4	)
Provision for income taxes		—			—			5			5
Balance at March 30, 2019	$	(173	)	$	(13	)	$	—		$	(186	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at December 30, 2017	$	(72	)	$	(17	)	$	9		$	(80	)
Other comprehensive income (loss) before reclassifications		7			—			21			28
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			2			2
Provision for income taxes		—			—			(6	)		(6	)
Balance at March 31, 2018	$	(65	)	$	(17	)	$	26		$	(56	)

Two Quarterly Periods Ended	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 29, 2018	$	(175	)	$	(13	)	$	32		$	(156	)
Other comprehensive income (loss) before reclassifications		2			—			(38	)		(36	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(5	)		(5	)
Provision for income taxes		—			—			11			11
Balance at March 30, 2019	$	(173	)	$	(13	)	$	—		$	(186	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 30, 2017	$	(48	)	$	(16	)	$	(4	)	$	(68	)
Other comprehensive income (loss) before reclassifications		(17	)		(1	)		35			17
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			6			6
Provision for income taxes		—			—			(11	)		(11	)
Balance at March 31, 2018	$	(65	)	$	(17	)	$	26		$	(56	)

Guarantor and Non-Guarantor Financial Information

6 Months Ended

Mar. 30, 2019

Guarantor and Non-Guarantor Financial Information [Abstract]

Guarantor and Non-Guarantor Financial Information

16. Guarantor and Non-Guarantor Financial Information

Berry Global, Inc. (“Issuer”) has notes outstanding which are fully, jointly, severally, and unconditionally guaranteed by its parent, Berry Global Group, Inc. (for purposes of this Note, “Parent”) and substantially all of Issuer’s domestic subsidiaries. Separate narrative information or financial statements of the guarantor subsidiaries have not been included because they are 100% owned by Parent and the guarantor subsidiaries unconditionally guarantee such debt on a joint and several basis. A guarantee of a guarantor subsidiary of the securities will terminate upon the following customary circumstances: the sale of the capital stock of such guarantor if such sale complies with the indentures, the designation of such guarantor as an unrestricted subsidiary, the defeasance or discharge of the indenture or in the case of a restricted subsidiary that is required to guarantee after the relevant issuance date, if such guarantor no longer guarantees certain other indebtedness of the issuer. The guarantees of the guarantor subsidiaries are also limited as necessary to prevent them from constituting a fraudulent conveyance under applicable law and any guarantees guaranteeing subordinated debt are subordinated to certain other of the Company’s debts. Parent also guarantees the Issuer’s term loans and revolving credit facilities. The guarantor subsidiaries guarantee our term loans and are co-borrowers under our revolving credit facility. Presented below is condensed consolidating financial information for the Parent, Issuer, guarantor subsidiaries and non-guarantor subsidiaries. The Issuer and guarantor financial information includes all of our domestic operating subsidiaries; our non-guarantor subsidiaries include our foreign subsidiaries, certain immaterial domestic subsidiaries and the unrestricted subsidiaries under the Issuer’s indentures. The Parent uses the equity method to account for its ownership in the Issuer in the Condensed Consolidating Supplemental Financial Statements. The Issuer uses the equity method to account for its ownership in the guarantor and non-guarantor subsidiaries. All consolidating entries are included in the eliminations column along with the elimination of intercompany balances.

Condensed Supplemental Consolidated Balance Sheet

	March 30, 2019
	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	258	$	1,255	$	754	$	—		$	2,267
Intercompany receivable		225		1,867		—		12		(2,104	)		—
Property, plant, and equipment, net		—		79		1,659		711		—			2,449
Other assets		1,675		6,376		4,776		479		(9,038	)		4,268
Total assets	$	1,900	$	8,580	$	7,690	$	1,956	$	(11,142	)	$	8,984

Current liabilities	$	12	$	264	$	581	$	270	$	—		$	1,127
Intercompany payable		—		—		2,104		—		(2,104	)		—
Other long-term liabilities		357		5,851		59		59		—			6,326
Stockholders' equity		1,531		2,465		4,946		1,627		(9,038	)		1,531
Total liabilities and stockholders' equity	$	1,900	$	8,580	$	7,690	$	1,956	$	(11,142	)	$	8,984

	September 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	249	$	1,240	$	796	$	—		$	2,285
Intercompany receivable		296		1,907		—		49		(2,252	)		—
Property, plant and equipment, net		—		79		1,684		725		—			2,488
Other assets		1,544		6,247		4,849		487		(8,769	)		4,358
Total assets	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Current liabilities	$	18	$	218	$	635	$	366	$	—		$	1,237
Intercompany payable		—		—		2,252		—		(2,252	)		—
Other long-term liabilities		388		5,945		68		59		—			6,460
Stockholders' equity		1,434		2,319		4,818		1,632		(8,769	)		1,434
Total liabilities and stockholders' equity	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Condensed Supplemental Consolidated Statements of Income

	Quarterly Period Ended March 30, 2019
	Parent			Issuer			Guarantor Subsidiaries		Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	137		$	1,362	$	451		$	—		$	1,950
Cost of goods sold		—			76			1,122		380			—			1,578
Selling, general and administrative		—			24			88		31			—			143
Amortization of intangibles		—			—			33		6			—			39
Restructuring and impairment charges		—			—			3		2			—			5
Operating income		—			37			116		32			—			185
Other expense (income), net		—			18			1		4			—			23
Interest expense, net		—			4			46		16			—			66
Equity in net income of subsidiaries		(96	)		(70	)		—		—			166			—
Income before income taxes		96			85			69		12			(166	)		96
Income tax expense		22			11			—		11			(22	)		22
Net income	$	74		$	74		$	69	$	1		$	(144	)	$	74
Comprehensive net income	$	74		$	67		$	69	$	(1	)	$	(144	)	$	65

	Quarterly Period Ended March 31, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Net sales	$	—		$	139		$	1,349	$	479	$	—		$	1,967
Cost of goods sold		—			95			1,103		398		—			1,596
Selling, general and administrative		—			18			83		29		—			130
Amortization of intangibles		—			—			31		7		—			38
Restructuring and impairment charges		—			—			9		6		—			15
Operating income (loss)		—			26			123		39		—			188
Other income, net		—			—			—		5		—			5
Interest expense, net		—			4			45		17		—			66
Equity in net income of subsidiaries		(117	)		(87	)		—		—		204			—
Income before income taxes		117			109			78		17		(204	)		117
Income tax expense		27			19			1		7		(27	)		27
Net income	$	90		$	90		$	77	$	10	$	(177	)	$	90
Comprehensive net income	$	90		$	94		$	77	$	30	$	(177	)	$	114

	Two Quarterly Periods Ended March 30, 2019
	Parent			Issuer			Guarantor Subsidiaries		Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	278		$	2,739	$	905		$	—		$	3,922
Cost of goods sold		—			161			2,264		772			—			3,197
Selling, general and administrative		—			37			175		55			—			267
Amortization of intangibles		—			—			69		12			—			81
Restructuring and impairment charges		—			—			10		6			—			16
Operating income		—			80			221		60			—			361
Other expense (income), net		—			19			2		2			—			23
Interest expense, net		—			9			91		30			—			130
Equity in net income of subsidiaries		(208	)		(137	)		—		—			345			—
Income before income taxes		208			189			128		28			(345	)		208
Income tax expense		46			27			—		19			(46	)		46
Net income	$	162		$	162		$	128	$	9		$	(299	)	$	162
Comprehensive net income	$	162		$	146		$	128	$	(5	)	$	(299	)	$	132

	Two Quarterly Periods Ended March 31, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Net sales	$	—		$	277		$	2,574	$	892	$	—		$	3,743
Cost of goods sold		—			201			2,092		750		—			3,043
Selling, general and administrative		—			30			163		54		—			247
Amortization of intangibles		—			—			62		14		—			76
Restructuring and impairment charges		—			—			16		10		—			26
Operating income		—			46			241		64		—			351
Other expense (income), net		—			5			7		2		—			14
Interest expense, net		—			9			88		31		—			128
Equity in net income of subsidiaries		(209	)		(159	)		—		—		368			—
Income before income taxes		209			191			146		31		(368	)		209
Income tax expense		(44	)		(62	)		1		17		44			(44	)
Net income	$	253		$	253		$	145	$	14	$	(412	)	$	253
Comprehensive net income	$	253		$	254		$	145	$	25	$	(412	)	$	265

Condensed Supplemental Consolidated Statements of Cash Flows

	Quarterly Period Ended March 30, 2019
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	67		$	281		$	(17	)	$	—		$	331
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			—			(141	)		(26	)		—			(167	)
Proceeds from sale of assets		—			—			—			—			—			—
(Contributions) distributions to/from subsidiaries		54			(54	)		—			—			—			—
Intercompany advances (repayments)		—			95			—			—			(95	)		—
Net cash from investing activities		54			41			(141	)		(26	)		(95	)		(167	)

Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(117	)		(4	)		(1	)		—			(122	)
Proceeds from issuance of common stock		20			—			—			—			—			20
Repurchase of common stock		(74	)		—			—			—			—			(74	)
Payment of tax receivable agreement		(16	)		—			—			—			—			(16	)
Changes in intercompany balances		16			—			(138	)		27			95			—
Net cash from financing activities		(54	)		(117	)		(142	)		26			95			(192	)

Effect of exchange rate changes on cash		—			—			—			—			—			—

Net change in cash		—			(9	)		(2	)		(17	)		—			(28	)
Cash and cash equivalents at beginning of period		—			133			4			244			—			381
Cash and cash equivalents at end of period	$	—		$	124		$	2		$	227		$	—		$	353

	Quarterly Period Ended March 31, 2018
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	14		$	258		$	13		$	—		$	285
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			(5	)		(137	)		(42	)		—			(184	)
Proceeds from sale of assets		—			—			—			3			—			3
(Contributions) distributions to/from subsidiaries		(12	)		(462	)		—			—			474			—
Intercompany advances (repayments)		—			137			—			—			(137	)		—
Acquisition of business, net of cash acquired		—			—			(404	)		(70	)		—			(474	)
Net cash from investing activities		(12	)		(330	)		(541	)		(109	)		337			(655	)

Cash Flow from Financing Activities
Proceeds from long-term borrowings		—			497			—			—			—			497
Repayments on long-term borrowings		—			(113	)		(4	)		—			—			(117	)
Proceeds from issuance of common stock		12			—			—			—			—			12
Payment of tax receivable agreement		(37	)		—			—			—			—			(37	)
Contribution from Parent		—			—			404			70			(474	)		—
Debt financing costs		—			(1	)		—			—			—			(1	)
Changes in intercompany balances		37			—			(116	)		(58	)		137			—
Net cash from financing activities		12			383			284			12			(337	)		354

Effect of exchange rate changes on cash		—			—			—			1			—			1

Net change in cash		—			67			1			(83	)		—			(15	)
Cash and cash equivalents at beginning of period		—			18			12			276			—			306
Cash and cash equivalents at end of period	$	—		$	85		$	13		$	193		$	—		$	291

Subsequent Events	6 Months Ended
Subsequent Events	Mar. 30, 2019
Subsequent Events [Abstract]
Subsequent Events	17. Subsequent Events In April 2019, the Company (i) amended and extended its existing revolving line of credit from total capacity of $750 million maturing in May 2020 to $850 million maturing in April 2024 and (ii) completed term loan amendments required to complete the RPC acquisition. The term loan amendments, which become effective upon completion of the RPC acquisition, will result in an increase of 0.25% to the applicable spread of each loan and a one-time 0.125% amendment fee.

Basis of Presentation (Policies)	6 Months Ended
Basis of Presentation (Policies)	Mar. 30, 2019
Basis of Presentation [Abstract]
Basis of Presentation	The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. ("the Company," "we," or "Berry") have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") pursuant to the rules and regulations of the Securities and Exchange Commission for interim reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements.
Use of Estimates	In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates.
Reclassifications	Certain reclassifications have been made to prior periods to conform to current reporting.

Recently Issued Accounting Pronouncements (Policies)	6 Months Ended
Recently Issued Accounting Pronouncements (Policies)	Mar. 30, 2019
Recently Issued Accounting Pronouncements [Abstract]
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Changes to GAAP are established by the Financial Accounting Standards Board ("FASB") in the form of accounting standards updates to the FASB's Accounting Standards Codification. During fiscal 2019, with the exception of the below, there have been no developments to the recently adopted accounting pronouncements from those disclosed in the Company's 2018 Annual Report on Form 10-K that are considered to have a material impact on our unaudited consolidated financial statements. Revenue Recognition In May 2014, the FASB issued a final standard on revenue recognition. Under the new standard, an entity should recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. For public entities, the provisions of the new standard are effective for annual reporting periods beginning after December 15, 2017 and interim periods therein. An entity can apply the new revenue standard on a full retrospective approach to each prior reporting period presented or on a modified retrospective approach with the cumulative effect of initially applying the standard recognized at the date of initial application in retained earnings. The Company adopted the new standard effective for fiscal 2019 using the modified retrospective approach. The adoption of this standard did not have a material impact on the Company's consolidated financial statements. Leases In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842), which increases transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet and disclosing key information about leasing arrangements. Under the new standard, the lessee of an operating lease will be required to do the following: 1) recognize a right-of-use asset and a lease liability in the statement of financial position, 2) recognize a single lease cost allocated over the lease term generally on a straight-line basis, and 3) classify all cash payments within operating activities on the statement of cash flows. Companies are required to adopt this standard using a modified retrospective transition method. Amendments in this standard are effective for fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company established a cross-functional implementation team that is progressing through inventorying its lease contracts and developing business processes and internal controls to ensure we meet the reporting and disclosure requirements of the new standard. The standard will be effective for the Company beginning fiscal 2020.

Acquisitions (Tables)

6 Months Ended

Mar. 30, 2019

Purchase Price Allocation

The following table summarizes the purchase price allocation and estimated fair values of the assets acquired and liabilities assumed at the date of the acquisition:

Working capital (a)	$	70
Property and equipment		164
Intangible assets		125
Goodwill		111
Other assets and long-term liabilities		5

(a) Includes a $3 million step up of inventory to fair value

Restructuring and Impairment Charges (Tables)

6 Months Ended

Mar. 30, 2019

Restructuring and Impairment Charges [Abstract]

Restructuring Charges by Segment

The tables below set forth the significant components of the restructuring charges recognized, by segment:

	Quarterly Period Ended				Two Quarterly Periods Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
Engineered Materials	$	1	$	2	$	1	$	2
Health, Hygiene & Specialties		2		12		12		22
Consumer Packaging		2		1		3		2
Consolidated	$	5	$	15	$	16	$	26

Restructuring Accrual Activity

The table below sets forth the activity with respect to the restructuring accrual at March 30, 2019:

	Employee Severance and Benefits			Facility Exit Costs			Non-cash Impairment Charges			Total
Balance at September 29, 2018	$	9		$	4		$	—		$	13
Charges		6			3			7			16
Non-cash asset impairment		—			—			(7	)		(7	)
Cash payments		(11	)		(2	)		—			(13	)
Balance at March 30, 2019	$	4		$	5		$	—		$	9

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities (Tables)

6 Months Ended

Mar. 30, 2019

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]

Accrued Expenses and Other Current Liabilities

The following table sets forth the totals included in Accrued expenses and other current liabilities on the Consolidated Balance Sheets:

	March 30, 2019		September 29, 2018
Employee compensation	$	107	$	113
Accrued taxes		73		72
Rebates		56		58
Interest		46		49
Derivative instruments		18		—
Tax receivable agreement obligation		12		16
Restructuring		9		13
Accrued operating expenses		112		95
	$	433	$	416

Other Long-Term Liabilities

The following table sets forth the totals included in Other long-term liabilities on the Consolidated Balance Sheets:

	March 30, 2019		September 29, 2018
Uncertain tax positions	$	70	$	67
Deferred purchase price		44		40
Pension liability		42		45
Lease retirement obligation		40		39
Derivative instruments		21		12
Sale-lease back deferred gain		20		21
Transition tax		17		18
Tax receivable agreement obligation		12		23
Other		24		24
	$	290	$	289

Long-Term Debt (Tables)

6 Months Ended

Mar. 30, 2019

Long-Term Debt [Abstract]

Long-Term Debt

Long-term debt consists of the following:

	Maturity Date	March 30, 2019			September 29, 2018
Term loan	February 2020^(a)	$	700		$	800
Term loan	January 2021		814			814
Term loan	October 2022		1,545			1,545
Term loan	January 2024		490			493
Revolving line of credit	May 2020		—			—
5 ¹/₂% Second Priority Senior Secured Notes	May 2022		500			500
6% Second Priority Senior Secured Notes	October 2022		400			400
5 ¹/₈% Second Priority Senior Secured Notes	July 2023		700			700
4 ¹/₂% Second Priority Senior Secured Notes	February 2026		500			500
Debt discounts and deferred fees			(38	)		(43	)
Capital leases and other	Various		116			135
Total long-term debt			5,727			5,844
Current portion of long-term debt			(37	)		(38	)
Long-term debt, less current portion		$	5,690		$	5,806

(a)	The Company classifies the term loan as long-term based on our intent and ability (through the use of alternative financing including our revolving line of credit, if necessary) to refinance prior to its maturity date.

Financial Instruments and Fair Value Measurements (Tables)

6 Months Ended

Mar. 30, 2019

Financial Instruments and Fair Value Measurements [Abstract]

Fair Value of Derivatives and Location on Consolidated Balance Sheets

Derivatives Instruments	Hedge Designation	Balance Sheet Location	March 30, 2019		September 29, 2018
Cross-currency swaps	Designated	Other assets	$	6	$	—
Cross-currency swaps	Designated	Other long-term liabilities		—		11
Interest rate swaps	Designated	Other assets		2		16
Interest rate swaps	Not designated	Other assets		—		—
Interest rate swaps	Designated	Other long-term liabilities		21		—
Interest rate swaps	Not designated	Other long-term liabilities		—		1
Foreign exchange forward contracts	Not designated	Other current liabilities		18		—

Effect of Derivatives on Consolidated Statements of Income

The effect of the Company's derivative instruments on the Consolidated Statements of Income is as follows:

		Quarterly Period Ended						Two Quarterly Periods Ended
Derivative Instruments	Statements of Income Location	March 30, 2019			March 31, 2018			March 30, 2019			March 31, 2018
Cross-currency swaps	Interest expense, net	$	(1	)	$	(1	)	$	(3	)	$	(2	)
Foreign exchange forward contracts	Other expense, net		18			—			18			—
Interest rate swaps	Interest expense, net		(5	)		1			(9	)		3

Assets Measured at Fair Value on Non-recurring Basis

	As of March 30, 2019
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,938		2,938		—
Definite lived intangible assets		—		—		1,015		1,015		—
Property, plant, and equipment		—		—		2,449		2,449		7
Total	$	—	$	—	$	6,650	$	6,650	$	7

	As of September 29, 2018
	Level 1		Level 2		Level 3		Total		Impairment
Indefinite-lived trademarks	$	—	$	—	$	248	$	248	$	—
Goodwill		—		—		2,944		2,944		—
Definite lived intangible assets		—		—		1,092		1,092		—
Property, plant, and equipment		—		—		2,488		2,488		—
Total	$	—	$	—	$	6,772	$	6,772	$	-

Operating Segments (Tables)

6 Months Ended

Mar. 30, 2019

Operating Segments [Abstract]

Selected Information by Reportable Segment

Selected information by reportable segment is presented in the following tables:

	Quarterly Period Ended				Two Quarterly Periods Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
Net sales:
Engineered Materials	$	628	$	655	$	1,297	$	1,303
Health, Hygiene & Specialties		683		706		1,385		1,283
Consumer Packaging		639		606		1,240		1,157
Total net sales	$	1,950	$	1,967	$	3,922	$	3,743
Operating income:
Engineered Materials	$	74	$	94	$	168	$	182
Health, Hygiene & Specialties		57		41		106		78
Consumer Packaging		54		53		87		91
Total operating income	$	185	$	188	$	361	$	351
Depreciation and amortization:
Engineered Materials	$	29	$	27	$	60	$	56
Health, Hygiene & Specialties		50		49		104		95
Consumer Packaging		53		56		106		110
Total depreciation and amortization	$	132	$	132	$	270	$	261

	March 30, 2019		September 29, 2018
Total assets:
Engineered Materials	$	1,997	$	1,998
Health, Hygiene & Specialties		3,772		3,913
Consumer Packaging		3,215		3,220
Total assets	$	8,984	$	9,131

Total goodwill:
Engineered Materials	$	630	$	632
Health, Hygiene & Specialties		899		902
Consumer Packaging		1,409		1,410
Total goodwill	$	2,938	$	2,944

Selected Information by Geography

Selected information by geography is presented in the following tables:

	Quarterly Period Ended				Two Quarterly Periods Ended
	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
Net sales:
North America	$	1,595	$	1,601	$	3,200	$	3,067
South America		88		80		184		154
Europe		210		226		414		396
Asia		57		60		124		126
Total net sales	$	1,950	$	1,967	$	3,922	$	3,743

	March 30, 2019		September 29, 2018
Long-lived assets:
North America	$	5,653	$	5,764
South America		327		320
Europe		437		463
Asia		300		299
Total Long-lived assets	$	6,717	$	6,846

Selected Information by Product Line

Selected information by product line is presented in the following tables:

	Quarterly Period Ended						Two Quarterly Periods Ended
	March 30, 2019			March 31, 2018			March 30, 2019			March 31, 2018
Net sales:
Performance Materials		40			45			39			46
Engineered Products		60			55			61			54
Engineered Materials		100	%		100	%		100	%		100	%

Health		17			18			17			19
Hygiene		51			43			52			43
Specialties		32			39			31			38
Health, Hygiene & Specialties		100	%		100	%		100	%		100	%

Rigid Open Top		43			41			44			42
Rigid Closed Top		57			59			56			58
Consumer Packaging		100	%		100	%		100	%		100	%

Basic and Diluted Net Income Per Share (Tables)

6 Months Ended

Mar. 30, 2019

Basic and Diluted Net Income Per Share [Abstract]

Basic and Diluted Net Income Per Share

The following tables provide a reconciliation of the numerator and denominator of the basic and diluted net income per share calculations.

	Quarterly Period Ended				Two Quarterly Periods Ended
(in millions, except per share amounts)	March 30, 2019		March 31, 2018		March 30, 2019		March 31, 2018
Numerator
Net income	$	74	$	90	$	162	$	253
Denominator
Weighted average common shares outstanding - basic		130.5		131.3		130.8		131.0
Dilutive shares		3.3		4.5		3.1		4.9
Weighted average common and common equivalent shares outstanding - diluted		133.8		135.8		133.9		135.9

Per common share income
Basic	$	0.57	$	0.69	$	1.24	$	1.93
Diluted	$	0.55	$	0.66	$	1.21	$	1.86

Accumulated Other Comprehensive Loss (Tables)

6 Months Ended

Mar. 30, 2019

Accumulated Other Comprehensive Loss [Abstract]

Accumulated Other Comprehensive Loss

The components and activity of Accumulated other comprehensive loss are as follows:

Quarterly Period Ended	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at December 29, 2018	$	(179	)	$	(13	)	$	15		$	(177	)
Other comprehensive income (loss) before reclassifications		6			—			(16	)		(10	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(4	)		(4	)
Provision for income taxes		—			—			5			5
Balance at March 30, 2019	$	(173	)	$	(13	)	$	—		$	(186	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at December 30, 2017	$	(72	)	$	(17	)	$	9		$	(80	)
Other comprehensive income (loss) before reclassifications		7			—			21			28
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			2			2
Provision for income taxes		—			—			(6	)		(6	)
Balance at March 31, 2018	$	(65	)	$	(17	)	$	26		$	(56	)

Two Quarterly Periods Ended	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 29, 2018	$	(175	)	$	(13	)	$	32		$	(156	)
Other comprehensive income (loss) before reclassifications		2			—			(38	)		(36	)
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			(5	)		(5	)
Provision for income taxes		—			—			11			11
Balance at March 30, 2019	$	(173	)	$	(13	)	$	—		$	(186	)

	Currency Translation			Defined Benefit Pension and Retiree Health Benefit Plans			Interest Rate Swaps			Accumulated Other Comprehensive Loss
Balance at September 30, 2017	$	(48	)	$	(16	)	$	(4	)	$	(68	)
Other comprehensive income (loss) before reclassifications		(17	)		(1	)		35			17
Net amount reclassified from accumulated other comprehensive income (loss)		—			—			6			6
Provision for income taxes		—			—			(11	)		(11	)
Balance at March 31, 2018	$	(65	)	$	(17	)	$	26		$	(56	)

Guarantor and Non-Guarantor Financial Information (Tables)

6 Months Ended

Mar. 30, 2019

Guarantor and Non-Guarantor Financial Information [Abstract]

Condensed Supplemental Consolidated Financial Information

Condensed Supplemental Consolidated Balance Sheet

	March 30, 2019
	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	258	$	1,255	$	754	$	—		$	2,267
Intercompany receivable		225		1,867		—		12		(2,104	)		—
Property, plant, and equipment, net		—		79		1,659		711		—			2,449
Other assets		1,675		6,376		4,776		479		(9,038	)		4,268
Total assets	$	1,900	$	8,580	$	7,690	$	1,956	$	(11,142	)	$	8,984

Current liabilities	$	12	$	264	$	581	$	270	$	—		$	1,127
Intercompany payable		—		—		2,104		—		(2,104	)		—
Other long-term liabilities		357		5,851		59		59		—			6,326
Stockholders' equity		1,531		2,465		4,946		1,627		(9,038	)		1,531
Total liabilities and stockholders' equity	$	1,900	$	8,580	$	7,690	$	1,956	$	(11,142	)	$	8,984

	September 29, 2018
	Parent		Issuer		Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Current assets	$	—	$	249	$	1,240	$	796	$	—		$	2,285
Intercompany receivable		296		1,907		—		49		(2,252	)		—
Property, plant and equipment, net		—		79		1,684		725		—			2,488
Other assets		1,544		6,247		4,849		487		(8,769	)		4,358
Total assets	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Current liabilities	$	18	$	218	$	635	$	366	$	—		$	1,237
Intercompany payable		—		—		2,252		—		(2,252	)		—
Other long-term liabilities		388		5,945		68		59		—			6,460
Stockholders' equity		1,434		2,319		4,818		1,632		(8,769	)		1,434
Total liabilities and stockholders' equity	$	1,840	$	8,482	$	7,773	$	2,057	$	(11,021	)	$	9,131

Condensed Supplemental Consolidated Statements of Income

	Quarterly Period Ended March 30, 2019
	Parent			Issuer			Guarantor Subsidiaries		Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	137		$	1,362	$	451		$	—		$	1,950
Cost of goods sold		—			76			1,122		380			—			1,578
Selling, general and administrative		—			24			88		31			—			143
Amortization of intangibles		—			—			33		6			—			39
Restructuring and impairment charges		—			—			3		2			—			5
Operating income		—			37			116		32			—			185
Other expense (income), net		—			18			1		4			—			23
Interest expense, net		—			4			46		16			—			66
Equity in net income of subsidiaries		(96	)		(70	)		—		—			166			—
Income before income taxes		96			85			69		12			(166	)		96
Income tax expense		22			11			—		11			(22	)		22
Net income	$	74		$	74		$	69	$	1		$	(144	)	$	74
Comprehensive net income	$	74		$	67		$	69	$	(1	)	$	(144	)	$	65

	Quarterly Period Ended March 31, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Net sales	$	—		$	139		$	1,349	$	479	$	—		$	1,967
Cost of goods sold		—			95			1,103		398		—			1,596
Selling, general and administrative		—			18			83		29		—			130
Amortization of intangibles		—			—			31		7		—			38
Restructuring and impairment charges		—			—			9		6		—			15
Operating income (loss)		—			26			123		39		—			188
Other income, net		—			—			—		5		—			5
Interest expense, net		—			4			45		17		—			66
Equity in net income of subsidiaries		(117	)		(87	)		—		—		204			—
Income before income taxes		117			109			78		17		(204	)		117
Income tax expense		27			19			1		7		(27	)		27
Net income	$	90		$	90		$	77	$	10	$	(177	)	$	90
Comprehensive net income	$	90		$	94		$	77	$	30	$	(177	)	$	114

	Two Quarterly Periods Ended March 30, 2019
	Parent			Issuer			Guarantor Subsidiaries		Non- Guarantor Subsidiaries			Eliminations			Total
Net sales	$	—		$	278		$	2,739	$	905		$	—		$	3,922
Cost of goods sold		—			161			2,264		772			—			3,197
Selling, general and administrative		—			37			175		55			—			267
Amortization of intangibles		—			—			69		12			—			81
Restructuring and impairment charges		—			—			10		6			—			16
Operating income		—			80			221		60			—			361
Other expense (income), net		—			19			2		2			—			23
Interest expense, net		—			9			91		30			—			130
Equity in net income of subsidiaries		(208	)		(137	)		—		—			345			—
Income before income taxes		208			189			128		28			(345	)		208
Income tax expense		46			27			—		19			(46	)		46
Net income	$	162		$	162		$	128	$	9		$	(299	)	$	162
Comprehensive net income	$	162		$	146		$	128	$	(5	)	$	(299	)	$	132

	Two Quarterly Periods Ended March 31, 2018
	Parent			Issuer			Guarantor Subsidiaries		Non- Guarantor Subsidiaries		Eliminations			Total
Net sales	$	—		$	277		$	2,574	$	892	$	—		$	3,743
Cost of goods sold		—			201			2,092		750		—			3,043
Selling, general and administrative		—			30			163		54		—			247
Amortization of intangibles		—			—			62		14		—			76
Restructuring and impairment charges		—			—			16		10		—			26
Operating income		—			46			241		64		—			351
Other expense (income), net		—			5			7		2		—			14
Interest expense, net		—			9			88		31		—			128
Equity in net income of subsidiaries		(209	)		(159	)		—		—		368			—
Income before income taxes		209			191			146		31		(368	)		209
Income tax expense		(44	)		(62	)		1		17		44			(44	)
Net income	$	253		$	253		$	145	$	14	$	(412	)	$	253
Comprehensive net income	$	253		$	254		$	145	$	25	$	(412	)	$	265

Condensed Supplemental Consolidated Statements of Cash Flows

	Quarterly Period Ended March 30, 2019
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	67		$	281		$	(17	)	$	—		$	331
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			—			(141	)		(26	)		—			(167	)
Proceeds from sale of assets		—			—			—			—			—			—
(Contributions) distributions to/from subsidiaries		54			(54	)		—			—			—			—
Intercompany advances (repayments)		—			95			—			—			(95	)		—
Net cash from investing activities		54			41			(141	)		(26	)		(95	)		(167	)

Cash Flow from Financing Activities
Repayments on long-term borrowings		—			(117	)		(4	)		(1	)		—			(122	)
Proceeds from issuance of common stock		20			—			—			—			—			20
Repurchase of common stock		(74	)		—			—			—			—			(74	)
Payment of tax receivable agreement		(16	)		—			—			—			—			(16	)
Changes in intercompany balances		16			—			(138	)		27			95			—
Net cash from financing activities		(54	)		(117	)		(142	)		26			95			(192	)

Effect of exchange rate changes on cash		—			—			—			—			—			—

Net change in cash		—			(9	)		(2	)		(17	)		—			(28	)
Cash and cash equivalents at beginning of period		—			133			4			244			—			381
Cash and cash equivalents at end of period	$	—		$	124		$	2		$	227		$	—		$	353

	Quarterly Period Ended March 31, 2018
	Parent			Issuer			Guarantor Subsidiaries			Non- Guarantor Subsidiaries			Eliminations			Total
Cash Flow from Operating Activities	$	—		$	14		$	258		$	13		$	—		$	285
Cash Flow from Investing Activities
Additions to property, plant, and equipment		—			(5	)		(137	)		(42	)		—			(184	)
Proceeds from sale of assets		—			—			—			3			—			3
(Contributions) distributions to/from subsidiaries		(12	)		(462	)		—			—			474			—
Intercompany advances (repayments)		—			137			—			—			(137	)		—
Acquisition of business, net of cash acquired		—			—			(404	)		(70	)		—			(474	)
Net cash from investing activities		(12	)		(330	)		(541	)		(109	)		337			(655	)

Cash Flow from Financing Activities
Proceeds from long-term borrowings		—			497			—			—			—			497
Repayments on long-term borrowings		—			(113	)		(4	)		—			—			(117	)
Proceeds from issuance of common stock		12			—			—			—			—			12
Payment of tax receivable agreement		(37	)		—			—			—			—			(37	)
Contribution from Parent		—			—			404			70			(474	)		—
Debt financing costs		—			(1	)		—			—			—			(1	)
Changes in intercompany balances		37			—			(116	)		(58	)		137			—
Net cash from financing activities		12			383			284			12			(337	)		354

Effect of exchange rate changes on cash		—			—			—			1			—			1

Net change in cash		—			67			1			(83	)		—			(15	)
Cash and cash equivalents at beginning of period		—			18			12			276			—			306
Cash and cash equivalents at end of period	$	—		$	85		$	13		$	193		$	—		$	291

Revenue Recognition (Details) - USD ($) $ in Millions	Mar. 30, 2019	Sep. 29, 2018
Revenue Recognition [Abstract]
Accrual for customer rebates	$ 56	$ 58

Acquisitions, RPC Group Plc (Details) - RPC Group Plc [Member] £ / shares in Units, £ in Millions, $ in Billions			12 Months Ended
	Mar. 08, 2019 USD ($) Site Process	Mar. 08, 2019 GBP (£) Site Country Process £ / shares	Mar. 31, 2018 GBP (£)
Acquisitions [Abstract]
Cash price per share offered to shareholders (in pounds per share) \| £ / shares		£ 7.93
Purchase price	$ 4.3	£ 3.3
Aggregate consideration	$ 6.5	£ 5.0
Total revenue \| £			£ 3.7
Number of operating sites \| Site	189	189
Number of countries where operating sites are located \| Country		34
Number of major polymer conversion processes in which products are manufactured \| Process	5	5

Acquisitions, Laddawn, Inc. (Details) - USD ($) $ in Millions	Aug. 31, 2018	Mar. 30, 2019	Sep. 29, 2018
Acquisitions [Abstract]
Goodwill		$ 2,938	$ 2,944
Laddawn [Member]
Acquisitions [Abstract]
Purchase price	$ 242
Working capital	26
Property and equipment	39
Intangible assets	98
Goodwill	79
Step up of inventory to fair value	$ 2

Acquisitions, Clopay Plastic Products Company, Inc. (Details) - USD ($)
$ in Millions

Feb. 28, 2018

Mar. 30, 2019

Sep. 29, 2018

Jan. 31, 2018

Allocation of Purchase Price [Abstract]

Goodwill

$ 2,938

$ 2,944

4.50% Second Priority Senior Secured Notes due 2026 [Member]

Face amount of debt issued

$ 500

4.50%

Clopay [Member]

Allocation of Purchase Price [Abstract]

Purchase price

$ 475

Working capital

^[1]

Property and equipment

164

Intangible assets

125

Goodwill

111

Other assets and long-term liabilities

Step up of inventory to fair value

$ 3

[1]	Includes a $3 million step up of inventory to fair value.

Accounts Receivable Factoring Agreements (Details) - USD ($) $ in Millions	Mar. 30, 2019	Sep. 29, 2018
Accounts Receivable Factoring Agreements [Abstract]
Amounts due from financial institutions	$ 0	$ 0
Trade receivables sold to financial institutions	$ 203	$ 162

Restructuring and Impairment Charges, Restructuring Charges by Segment (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018
Restructuring Charges [Abstract]
Restructuring charges	$ 5	$ 15	$ 16	$ 26
Engineered Materials [Member]
Restructuring Charges [Abstract]
Restructuring charges	1	2	1	2
Health, Hygiene & Specialties [Member]
Restructuring Charges [Abstract]
Restructuring charges	2	12	12	22
Consumer Packaging [Member]
Restructuring Charges [Abstract]
Restructuring charges	$ 2	$ 1	$ 3	$ 2

Restructuring and Impairment Charges, Restructuring Accrual Activity (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 30, 2019	Mar. 31, 2018	Mar. 30, 2019	Mar. 31, 2018	Sep. 29, 2018
Restructuring Accrual [Roll Forward]
Beginning balance			$ 13
Charges	$ 5	$ 15	16	$ 26
Non-cash asset impairment			(7)		$ 0
Cash payments			(13)
Ending balance	9		9		13
Employee Severance and Benefits [Member]
Restructuring Accrual [Roll Forward]
Beginning balance			9
Charges			6
Non-cash asset impairment			0
Cash payments			(11)
Ending balance	4		4		9
Facility Exit Costs [Member]
Restructuring Accrual [Roll Forward]
Beginning balance			4
Charges			3
Non-cash asset impairment			0
Cash payments			(2)
Ending balance	5		5		4
Non-Cash Impairment Charges [Member]
Restructuring Accrual [Roll Forward]
Beginning balance			0
Charges			7
Non-cash asset impairment			(7)
Cash payments			0
Ending balance	$ 0		$ 0		$ 0

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Accrued Expenses and Other Current Liabilities (Details) - USD ($) $ in Millions	Mar. 30, 2019	Sep. 29, 2018
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Employee compensation	$ 107	$ 113
Accrued taxes	73	72
Rebates	56	58
Interest	46	49
Derivative instruments	18	0
Tax receivable agreement obligation	12	16
Restructuring	9	13
Accrued operating expenses	112	95
Accrued expenses and other current liabilities	$ 433	$ 416

Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities, Other Long-Term Liabilities (Details) - USD ($) $ in Millions	Mar. 30, 2019	Sep. 29, 2018
Accrued Expenses, Other Current Liabilities and Other Long-Term Liabilities [Abstract]
Uncertain tax positions	$ 70	$ 67
Deferred purchase price	44	40
Pension liability	42	45
Lease retirement obligation	40	39
Derivative instruments	21	12
Sale-lease back deferred gain	20	21
Transition tax	17	18
Tax receivable agreement obligation	12	23
Other	24	24
Other long-term liabilities	$ 290	$ 289

Long-Term Debt, Summary of Long-Term Debt (Details) - USD ($)
$ in Millions

6 Months Ended

Mar. 30, 2019

Mar. 31, 2018

Sep. 29, 2018

Debt discounts and deferred fees

$ (38)

$ (43)

Capital leases and other

116

135

Total long-term debt

5,727

5,844

Current portion of long-term debt

(37)

(38)

Long-term debt, less current portion

5,690

5,806

Repayments on long-term borrowings

122

$ 117

Term Loan due February 2020 [Member]

$ 700

800

Term Loan due January 2021 [Member]

^[1]

Feb. 29, 2020

$ 814

814

Term Loan due October 2022 [Member]

Jan. 31, 2021

$ 1,545

1,545

Term Loan due January 2024 [Member]

Oct. 31, 2022

$ 490

493

Revolving Line of Credit [Member]

Jan. 31, 2024

$ 0

5 1/2% Second Priority Senior Secured Notes due May 2022 [Member]

May 31, 2020

$ 500

500

5.50%

6% Second Priority Senior Secured Notes due October 2022 [Member]

May 31, 2022

$ 400

400

6.00%

5 1/8% Second Priority Senior Secured Notes due July 2023 [Member]

Oct. 31, 2022

$ 700

700

5.125%

4 1/2% Second Priority Senior Secured Notes due February 2026 [Member]

Jul. 31, 2023

$ 500

4.50%